Navigation Links
NSAIDS, Reduces The Risk Of Oral Cancer But Causes Heart Attacks

Researchers from Norwegian Radium Hospital and National Hospital, Oslo and other collaborating Universities from many cancer Institutes has presented their study data conducted over 20 years in 900 adults has found that // long use of Non-steroidal Anti-inflammatory drugs (NSAIDs), reduces the risk of oral cancer in smoking individuals by at least 50%. But the drug also has the risk of developing cardiovascular deaths, the study has found that use of NSAIDs for more than 6 months increased the risk of developing cardiovascular deaths. The study was funded by U.S. National Cancer Institute and other councils. The data was analyzed from 1975 to 1995 in more than 123,000 adults by surveying the lifestyles, habits, and long term health of the study participants.

"Our findings highlight how a commonly used drug can have a benefit from the standpoint of cancer prevention but can also have side effects - in this case, an increased risk for cardiovascular death," said co-researcher Dr. Andrew Dannenberg, the Henry R. Erle, M.D., Professor of Medicine at Weill Medical College of Cornell University and Director of Cancer Prevention at New York-Presbyterian /Weill Cornell.

"Specifically, we were looking for associations between the long-term use of traditional, non-COX-2-specific NSAIDs and the risk of oral cancer, since previous work has suggested that these drugs can lower risks for other malignancies, such as colon cancer," explained co-researcher Dr. Scott M. Lippman, Ellen F. Knisely Distinguished Chair and Chairman of the Department of Clinical Cancer Prevention at M. D. Anderson Cancer Center.

Adults who were prescribed NSAIDs such as aspirin, ibuprofen, naproxen, indomethacin, piroxicam, and ketoprofen for 6 months or more (most of them for much longer periods, with 88 percent taking NSAIDs for 5 years or more) were at a 53 percent lowered risk for oral malignancies compared with those who did not take the drugs over the long-term, tho ugh the results show that the drugs reduced the risk of oral cancer, the drug did not give any benefit in reduction of the disease.

Dr. Dannenberg and co-author Dr. J. Jack Lee, Professor of Biostatistics at the M. D. Anderson Cancer Center, stressed that although the data themselves were collected prospectively, the study remains a relatively small, retrospective effort. "It's tough to make sweeping generalizations until the results are confirmed by much larger, prospective trials," they said.

Source: News wise.
'"/>




Related medicine news :

1. Drug Reduces Risk of Clogged Arteries, Veins
2. Sunshine Reduces MS Risk
3. Estrogen in Food Reduces Cancer Risk
4. Dental Procedure Reduces Preterm Births
5. Vaccine Reduces antibiotic-resistant infections in Children
6. Eating Fiber Reduces The Risk Of Heart Disease
7. Higher Statin Dose Safely Reduces Stroke and Cardiac Arrest
8. Anti-tobacco Advertising Can Reduces smoking Among Teens
9. Eating Fish Reduces Heart Disease
10. Co-trimoxazole Use Reduces Childhood AIDS –Related Death
11. Oxytocin Boosts Trust and Reduces Fear.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... Doylestown, Pa. (PRWEB) , ... ... ... leading provider of technology-enabled clinical trial solutions, today announced the further expansion ... types of applications they can leverage as part of Bioclinica’s extensive and ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article ... weight loss. It found that the treatments have led to significant improvements in weight ... to unassisted efforts. It also noted very few problematic results relating to the treatment. ...
(Date:2/20/2017)... ... February 21, 2017 , ... Nancy Johnston Toll marks her debut ... Getting Over the Bump in the Road ” (published by Xlibris). Inspired from her ... cope with the ups and downs experienced by anyone going through cancer treatment and ...
(Date:2/20/2017)... ... February 20, 2017 , ... Researchers at the University of ... well as a marker that may predict response to a particular class of drugs, ... of cancer as well. The new findings were published in Proceedings of the National ...
(Date:2/20/2017)... ... 2017 , ... Best Doctors® and IBM today announced that ... that want to help members of their workforce battling cancer. Through the Best ... suite of oncology offerings for insights on cancer treatment options, ranging from standard ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... Lexmark International, ... solution that connects Lexmark multifunction printers (MFPs) to EDCO ... leading scanning and indexing software solutions for medical records. ... use a Lexmark MFP at the point of care ... facilities reach HIMSS Stage 7 through state-of-the-art ...
(Date:2/21/2017)... IDAHO FALLS, Idaho , Feb. 21, 2017 /PRNewswire/ ... is has completed a private placement with certain investors ... preferred stock of the Company, Series C Convertible Redeemable ... Stock accrues dividends at an annual rate of 6% ... share.  The Company plans to use the proceeds for ...
(Date:2/21/2017)... SAN JOSE, Calif. , Feb. 21, 2017 ... announced that its Cadence ® Tensilica ® Fusion ... HaLow ™ MAC IP offering. The licensable IP targets ... smart city and industrial applications. M2B leveraged the Fusion F1 ... to run value-added applications like voice trigger, audio identification and ...
Breaking Medicine Technology: